1. Home
  2. SFIX vs GLUE Comparison

SFIX vs GLUE Comparison

Compare SFIX & GLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFIX
  • GLUE
  • Stock Information
  • Founded
  • SFIX 2011
  • GLUE 2019
  • Country
  • SFIX United States
  • GLUE United States
  • Employees
  • SFIX N/A
  • GLUE N/A
  • Industry
  • SFIX Catalog/Specialty Distribution
  • GLUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFIX Consumer Discretionary
  • GLUE Health Care
  • Exchange
  • SFIX Nasdaq
  • GLUE Nasdaq
  • Market Cap
  • SFIX 589.8M
  • GLUE 475.5M
  • IPO Year
  • SFIX 2017
  • GLUE 2021
  • Fundamental
  • Price
  • SFIX $4.13
  • GLUE $7.60
  • Analyst Decision
  • SFIX Hold
  • GLUE Buy
  • Analyst Count
  • SFIX 9
  • GLUE 3
  • Target Price
  • SFIX $3.96
  • GLUE $14.67
  • AVG Volume (30 Days)
  • SFIX 4.8M
  • GLUE 1.5M
  • Earning Date
  • SFIX 12-10-2024
  • GLUE 11-07-2024
  • Dividend Yield
  • SFIX N/A
  • GLUE N/A
  • EPS Growth
  • SFIX N/A
  • GLUE N/A
  • EPS
  • SFIX N/A
  • GLUE N/A
  • Revenue
  • SFIX $1,291,501,000.00
  • GLUE $14,975,000.00
  • Revenue This Year
  • SFIX N/A
  • GLUE N/A
  • Revenue Next Year
  • SFIX N/A
  • GLUE N/A
  • P/E Ratio
  • SFIX N/A
  • GLUE N/A
  • Revenue Growth
  • SFIX N/A
  • GLUE N/A
  • 52 Week Low
  • SFIX $2.06
  • GLUE $3.21
  • 52 Week High
  • SFIX $6.99
  • GLUE $12.40
  • Technical
  • Relative Strength Index (RSI)
  • SFIX 48.27
  • GLUE 42.74
  • Support Level
  • SFIX $3.75
  • GLUE $7.36
  • Resistance Level
  • SFIX $6.99
  • GLUE $7.95
  • Average True Range (ATR)
  • SFIX 0.53
  • GLUE 0.86
  • MACD
  • SFIX -0.12
  • GLUE -0.28
  • Stochastic Oscillator
  • SFIX 11.75
  • GLUE 8.99

About SFIX Stitch Fix Inc.

Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.

About GLUE Monte Rosa Therapeutics Inc.

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their most advanced product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.

Share on Social Networks: